Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
- PMID: 28994807
- PMCID: PMC5752260
- DOI: 10.3791/56105
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Abstract
In recent years, biomarker diagnostics became an indispensable tool for the diagnosis of human disease, especially for the point-of-care diagnostics. An easy-to-use and low-cost sensor platform is highly desired to measure various types of analytes (e.g., biomarkers, hormones, and drugs) quantitatively and specifically. For this reason, dry film photoresist technology - enabling cheap, facile, and high-throughput fabrication - was used to manufacture the microfluidic biosensor presented here. Depending on the bioassay used afterwards, the versatile platform is capable of detecting various types of biomolecules. For the fabrication of the device, platinum electrodes are structured on a flexible polyimide (PI) foil in the only clean-room process step. The PI foil serves as a substrate for the electrodes, which are insulated with an epoxy-based photoresist. The microfluidic channel is subsequently generated by the development and lamination of dry film photoresist (DFR) foils onto the PI wafer. By using a hydrophobic stopping barrier in the channel, the channel is separated into two specific areas: an immobilization section for the enzyme-linked assay and an electrochemical measurement cell for the amperometric signal readout. The on-chip bioassay immobilization is performed by the adsorption of the biomolecules to the channel surface. The glucose oxidase enzyme is used as a transducer for electrochemical signal generation. In the presence of the substrate, glucose, hydrogen peroxide is produced, which is detected at the platinum working electrode. The stop-flow technique is applied to obtain signal amplification along with rapid detection. Different biomolecules can quantitatively be measured by means of the introduced microfluidic system, giving an indication of different types of diseases, or, in regard to therapeutic drug monitoring, facilitating a personalized therapy.
Similar articles
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
-
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887. Elife. 2025. PMID: 40407808 Free PMC article.
-
An electrochemical biosensor for the amplification of thrombin activity by perylene-mediated photoinitiated polymerization.Anal Chim Acta. 2024 May 8;1302:342494. doi: 10.1016/j.aca.2024.342494. Epub 2024 Mar 20. Anal Chim Acta. 2024. PMID: 38580414
-
Electrochemical detection of foodborne Escherichia coli using carbon nanotube-incorporated pencil-drawn paper-based disposable biosensors.Anal Chim Acta. 2025 Oct 1;1369:344344. doi: 10.1016/j.aca.2025.344344. Epub 2025 Jun 19. Anal Chim Acta. 2025. PMID: 40701715
-
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080. Br J Dermatol. 2024. PMID: 38419411 Free PMC article. Review.
Cited by
-
Biosensor-Enabled Multiplexed On-Site Therapeutic Drug Monitoring of Antibiotics.Adv Mater. 2022 Jan;34(2):e2104555. doi: 10.1002/adma.202104555. Epub 2021 Sep 21. Adv Mater. 2022. PMID: 34545651 Free PMC article.
-
Designing electrochemical microfluidic multiplexed biosensors for on-site applications.Anal Bioanal Chem. 2022 Sep;414(22):6531-6540. doi: 10.1007/s00216-022-04210-4. Epub 2022 Jul 6. Anal Bioanal Chem. 2022. PMID: 35794347 Free PMC article.
-
Label-free, real-time monitoring of cytochrome C drug responses in microdissected tumor biopsies with a multi-well aptasensor platform.Sci Adv. 2024 Sep 6;10(36):eadn5875. doi: 10.1126/sciadv.adn5875. Epub 2024 Sep 6. Sci Adv. 2024. PMID: 39241078 Free PMC article.
-
Low-cost and cleanroom-free prototyping of microfluidic and electrochemical biosensors: Techniques in fabrication and bioconjugation.Biomicrofluidics. 2021 Nov 8;15(6):061502. doi: 10.1063/5.0071176. eCollection 2021 Dec. Biomicrofluidics. 2021. PMID: 34777677 Free PMC article. Review.
References
-
- Luppa PB, Bietenbeck A, Beaudoin C, Giannetti A. Clinically relevant analytical techniques, organizational concepts for application and future perspectives of point-of-care testing. Biotechnol Adv. 2016;34(3):139–160. - PubMed
-
- Gauglitz G. Point-of-Care Platforms. Annu Rev Anal Chem. 2014;7(1):297–315. - PubMed
-
- Jung W, Han J, Choi JW, Ahn CH. Point-of-care testing (POCT) diagnostic systems using microfluidic lab-on-a-chip technologies. Microelectron Eng. 2014;132:46–57.
-
- Yager P, et al. Microfluidic diagnostic technologies for global public health. Nature. 2006;442(7101):412–418. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous